Metraipolis › archive › dc_a5ba0671eebe

Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer — Europe PMC PMID:42358841

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358841
DOI
10.32604/or.2026.067443
License (as archived)
solo-consultazione
Archived
2026-10-19T09:27:53.071Z
SHA-256 of the archived text
c452ef1b0c165b720c64b2fe3107400cd248b09a531b1dd1d9f1793ba3773b7f
Stable URL of this page
https://metraipolis.com/documento/dc_a5ba0671eebe

How to cite

Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer — Europe PMC PMID:42358841 — Europe PMC (en), https://europepmc.org/article/MED/42358841 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5ba0671eebe (Metraipolis archive dc_a5ba0671eebe, sha256 c452ef1b0c165b720c64b2fe3107400cd248b09a531b1dd1d9f1793ba3773b7f)
BibTeX
@misc{dca5ba0671eebe,
  title = {Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer — Europe PMC PMID:42358841},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358841},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5ba0671eebe; sha256 c452ef1b0c165b720c64b2fe3107400cd248b09a531b1dd1d9f1793ba3773b7f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358841. Agents can read the archived copy with the MCP tool read_document.